Search | Page 12 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Recent developments in myelodysplastic syndromes

    ... chromosomal abnormalities, bone marrow blasts , cytopenias, age, and additional factors to determine prognosis.  ...

    Research Review last updated 05/02/2016 - 9:16am.

  2. Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR

    ... high risk and CMML with bone marrow blasts <5%); or Secondary acute myeloid leukemia on the basis of ...

    Clinical Trial last updated 05/02/2016 - 11:10am.

  3. Kathryn (Kate) Bauer, Retired MDS Patient Living Life to the Fullest Since Transplant

    ... stage was Refractory Anemia with Excess Blasts (RAEB-1) with one chromosomal abnormality. In February 2010, I ...

    Patient Chronicle last updated 07/23/2015 - 9:38am.

  4. Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients

    ... Patients with AML must have ≥ 5% leukemic blasts in the bone marrow or have converted from negative minimal ...

    Clinical Trial last updated 05/09/2016 - 3:01pm.

  5. Pediatric MDS

    ... leukemias (AML) by having a relatively low percentage of blasts (immature blood cells in the bone marrow). There’s really no ...

    Interview last updated 10/24/2012 - 1:31pm.

  6. Myelodysplastic syndromes: What do hospitalists need to know?

    ... the percentage of immature cells in the bone marrow ( blasts ), number of cell lines affected by low blood counts (0-3), and ...

    Research Review last updated 05/02/2016 - 9:21am.

  7. Preventing Stem Cell Transplant Complications With a Blood Separator Machine

    ... with ANC< 500/microL, refractory anemia with excess of blasts , transformation to acute leukemia, chronic myelomonocytic leukemia, ...

    Clinical Trial last updated 05/23/2016 - 10:57am.

  8. Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow

    ... MDS: refractory anemia with excess blasts (RAEB), or chronic myelomonocyte leukemia (CMML). ...

    Clinical Trial last updated 04/28/2016 - 2:08pm.

  9. Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant

    ... morphologic relapse/ persistent disease defined as > 5% blasts in normocellular bone marrow OR any % blasts if blasts have unique morphologic markers (e.g. Auer rods) or associated ...

    Clinical Trial last updated 05/02/2016 - 2:13pm.

  10. Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases

    ... morphologic relapse/ persistent disease defined as > 5% blasts in normocellular bone marrow OR any % blasts if blasts have unique morphologic markers (e.g. Auer rods) or associated ...

    Clinical Trial last updated 06/06/2016 - 10:54am.